Investor directory

MD Anderson Cancer Center

MD Anderson Cancer Center, based in Houston, Texas, is a leading provider of cancer treatment services dedicated to eliminating cancer. It integrates patient care, research, and prevention in its mission, while also focusing on education for students, trainees, professionals, and the public. As a degree-granting academic institution, MD Anderson not only treats cancer patients but also advances the field through research initiatives. Its comprehensive approach combines clinical services with educational programs to enhance the understanding and treatment of cancer, positioning it as a vital institution in the fight against this disease.
http://www.mdanderson.org
https://crunchbase.com/organization/md-anderson-cancer-center-19d6
https://facebook.com/mdanderson
https://linkedin.com/company/mdandersoncancercenter
https://pitchbook.com/profiles/company/94307-23
https://twitter.com/mdandersonnews

William Simeone Jr.

Vice President for Operations and Chief Quality Officer

1 past transactions

Magnolia NeuroSciences

Series A in 2018
Magnolia Neurosciences Corporation is a New York-based company focused on drug discovery and development, specifically targeting neuroprotective therapies for central nervous system diseases and neurodegeneration. Established in 2018, the company aims to create proprietary small molecule therapeutics that prevent neuronal cell death, offering new treatment options for patients with neurodegenerative disorders and related conditions. Magnolia Neurosciences was founded to advance technologies developed at The University of Texas MD Anderson Cancer Center’s Therapeutics Discovery Division and the Neurodegeneration Consortium. Through its innovative approach, the company seeks to address significant medical needs in the field of neurology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.